Toyoda H - Search Results

1

Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.

Redford A, Magalong D, Onohara-Toyoda M, Tyan D, Riley WJ, Maclaren NK, Rotter JI, Toyoda H. Redford A, et al. Among authors: toyoda h. Dis Markers. 1991 Sep-Oct;9(5):257-63. Dis Markers. 1991. PMID: 1686750

2

Application of synthetic oligonucleotides to detect DQ beta genes transmission within insulin-dependent diabetes families.

Toyoda H, Onohara-Toyoda M, Krull J, Vadheim CM, Bickal JC, Riley WJ, MacLaren NK, Itakura K, Rotter JI. Toyoda H, et al. Dis Markers. 1989 Oct-Dec;7(4):215-28. Dis Markers. 1989. PMID: 2573447

3

Distinct associations of HLA class II genes with inflammatory bowel disease.

Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, Pressman SR, Shanahan F, Targan SR, et al. Toyoda H, et al. Gastroenterology. 1993 Mar;104(3):741-8. doi: 10.1016/0016-5085(93)91009-7. Gastroenterology. 1993. PMID: 8440433

4

Allele-specific methylation in the 5'-regulatory region of class II DQ beta genes in the human major histocompatibility complex (MHC): relationship to autoimmune disease susceptibility.

Toyoda H, Redford A, Magalong D. Toyoda H, et al. Dis Markers. 1992 Jan-Feb;10(1):7-18. Dis Markers. 1992. PMID: 1424441

5

The aggregation of the 5' insulin gene polymorphism in insulin dependent (type I) diabetes mellitus families.

Raffel LJ, Hitman GA, Toyoda H, Karam JH, Bell GI, Rotter JI. Raffel LJ, et al. Among authors: toyoda h. J Med Genet. 1992 Jul;29(7):447-50. J Med Genet. 1992. PMID: 1353534 Free PMC article.

6

Lack of an association between polymorphisms of the T-cell receptor alpha-chain and ulcerative colitis.

Randolph LM, Toyoda H, McElree CK, Shanahan F, Targan SR, Rotter JI. Randolph LM, et al. Among authors: toyoda h. Gastroenterology. 1989 Nov;97(5):1115-20. doi: 10.1016/0016-5085(89)91680-6. Gastroenterology. 1989. PMID: 2571544

7

Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.

Yang H, Rotter JI, Toyoda H, Landers C, Tyran D, McElree CK, Targan SR. Yang H, et al. Among authors: toyoda h. J Clin Invest. 1993 Aug;92(2):1080-4. doi: 10.1172/JCI116613. J Clin Invest. 1993. PMID: 8349790 Free PMC article.

8

In situ islet T cell receptor variable region gene usage in the nonobese diabetic mouse.

Toyoda H, Redford A, Magalong D, Chan E, Hosszufalusi N, Formby B, Teruya M, Charles MA. Toyoda H, et al. Immunol Lett. 1992 May;32(3):241-5. doi: 10.1016/0165-2478(92)90056-t. Immunol Lett. 1992. PMID: 1379982

9

Precise gene dosage determination by polymerase chain reaction: theory, methodology, and statistical approach.

Lubin MB, Elashoff JD, Wang SJ, Rotter JI, Toyoda H. Lubin MB, et al. Among authors: toyoda h. Mol Cell Probes. 1991 Aug;5(4):307-17. doi: 10.1016/0890-8508(91)90054-n. Mol Cell Probes. 1991. PMID: 1791851

10

In situ islet cytokine gene expression during development of type I diabetes in the non-obese diabetic mouse.

Toyoda H, Formby B, Magalong D, Redford A, Chan E, Takei S, Charles MA. Toyoda H, et al. Immunol Lett. 1994 Mar;39(3):283-8. doi: 10.1016/0165-2478(94)90170-8. Immunol Lett. 1994. PMID: 8034342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,489 results

Search Page

Filters